Delivery Order SPE2DB25D3201-SPE2DB25FNVRG
- Not listed
- The Defense Logistics Agency awarded a $2,601.43 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Forteo (560 mcg/2.24 mL pen injections) with an ultimate completion date of August 22, 2025. This non-competitive delivery order represents a single pharmaceutical procurement from the company's extensive federal contract portfolio. The place of performance is identified as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,343.69 to AmerisourceBergen Drug Corp for the supply of Forteo (560 mcg/2.24 mL pen injections). This firm fixed-price contract, awarded on June 6, 2025, with an ultimate completion date of June 9, 2025, represents a non-competitive set-aside delivery order executed through the company's existing contract vehicle with DLA. The pharmaceutical product will be delivered to the Place of Performance in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,288.59 to AmerisourceBergen Drug Corp for the supply of Forteo (560 mcg/2.24 mL pen injection). This is a firm fixed price, non-set-aside contract with an ultimate completion date of April 29, 2025, issued on April 28, 2025. AmerisourceBergen will perform and deliver from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's existing Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $10,392.66 to AmerisourceBergen Drug Corp for the supply of Forteo (560 mcg/2.24 ml pen injections) on July 23, 2025, with completion scheduled for July 24, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $49,054.76 to AmerisourceBergen Drug Corp for the supply of Forteo (560 mcg/2.24 mL pen injections) on August 20, 2025, with completion scheduled for August 21, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The place of performance is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,575.97 to AmerisourceBergen Drug Corp for the supply of Forteo 560 mcg/2.24 mL pen injections (2.24 mL units). This firm fixed-price contract, awarded on June 25, 2025, with an ultimate completion date of June 26, 2025, was competitively awarded with no set-aside designation. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Forteo is a FDA-approved medication used to treat...
- The Defense Logistics Agency awarded a $16,156.03 firm fixed price delivery order to AmerisourceBergen Drug Corp for Forteo 560 mcg/2.24 mL pen injections on May 30, 2025, with an ultimate completion date of June 2, 2025. This is a non-set-aside delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion and extending through December 2026. The product will be delivered to AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Forteo (560 mcg/2.24 mL pen injections) valued at $14,661.05. This firm fixed-price delivery order, with an ultimate completion date of August 21, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award utilized no set-aside designation and was competitively awarded through open competition. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $4,968.17 on May 27, 2025, for the supply of Forteo (560 mcg/2.24 mL pen injection). This firm fixed-price delivery order, which completes on May 28, 2025, was competitively awarded without a set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete transaction under the company's larger...
- The Defense Logistics Agency (DLA) awarded a $59,949.31 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Forteo (teriparatide) 560 mcg/2.24 mL pen injections, with an ultimate completion date of April 25, 2025. This non-set-aside contract was competitively awarded and represents a single delivery order for pharmaceutical supply supporting federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor...
- SPE2DB25D3201Indefinite Delivery Contract
- SPE2DB25D3201-SPE2DB25FNVRGDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $25,087.66 to AmerisourceBergen Drug Corp for the supply of Forteo (560 mcg/2.24 mL pen injections) under a firm fixed-price contract. This non-set-aside award, issued on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a single delivery transaction for pharmaceutical supplies to support federal medical procurement needs. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026 that enables the contractor to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs globally. AmerisourceBergen, one of the nation's largest pharmaceutical distributors, regularly fulfills federal medical supply requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through competitive awards with the DLA, demonstrating significant capability in delivering specialized medications across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.1k | 8/14/25 |